Overall, the work presented herein provides new avenues for the development of more potent antibodies and small-molecule inhibitors of the TIM/TIPIN complex that could be used alone or in combination with small-molecule inhibitors, which could be a promising drug to treat melanoma in the future. This evidence concerns the gene TIPIN and melanoma.